Leading The Way In Pediatric Endo-Cannabinoid Medicine
Phyto Therapeutic Medicine for Inflammatory Conditions
Initial 2.2 Million Square Feet of Cultivation
Exclusive Clinically Validated Formulations
Innovation in Skin Care and Anti-Aging Systems
Relevium’s CEO Provides an Open Shareholder Letter for 2020
by Olga Tkach | December 19, 2019 | 2019 Press Releases | 0 Comments
MONTREAL, Dec. 19, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to provide an open letter to its shareholders from the company’s Chief Executive Officer, Aurelio...Relevium Launches LeefyLyfe™ Organic Hemp Products in the US
by Olga Tkach | November 20, 2019 | 2019 Press Releases | 0 Comments
MONTREAL, Nov. 20, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce the launch of LeefyLyfeTM Organics, a comprehensive line of organic health and wellness...Relevium Executes LOI to Acquire Montreal Biopharma Contract Manufacturing Company
by Olga Tkach | November 8, 2019 | 2019 Press Releases | 0 Comments
MONTREAL, Nov. 08, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce it has executed a letter of intent to acquire a Montreal based biopharma contract...Relevium Technologies
Relevium is a publicly traded corporation strategically focused on the expansion and acquisition of entrepreneurial brands within the health and wellness sector. Our focus is on being a trusted source of high-quality nutraceutical and CBD products.contact us
Relevium Technologies Inc.
1000 Sherbrooke West, Suite 2700
Montreal, QC, H3A 3G4
(888) 528-8687
www.releviumtechnologies.com
info@releviumtechnologies.com
trading information
Market data is delayed by 15 minutes
Relevium’s CEO Provides an Open Shareholder Letter for 2020
by Olga Tkach | December 19, 2019 | 2019 Press Releases | 0 Comments
MONTREAL, Dec. 19, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to provide an open letter to its shareholders from the company’s Chief Executive Officer, Aurelio...Relevium Launches LeefyLyfe™ Organic Hemp Products in the US
by Olga Tkach | November 20, 2019 | 2019 Press Releases | 0 Comments
MONTREAL, Nov. 20, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce the launch of LeefyLyfeTM Organics, a comprehensive line of organic health and wellness...Relevium Executes LOI to Acquire Montreal Biopharma Contract Manufacturing Company
by Olga Tkach | November 8, 2019 | 2019 Press Releases | 0 Comments
MONTREAL, Nov. 08, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce it has executed a letter of intent to acquire a Montreal based biopharma contract...